- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging Therapies for Hepatocellular Carcinoma (HCC)
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 11, Pages 2798
Publisher
MDPI AG
Online
2022-06-04
DOI
10.3390/cancers14112798
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune-checkpoint inhibitors: long-term implications of toxicity
- (2022) Douglas B. Johnson et al. Nature Reviews Clinical Oncology
- FDA approves second BCMA-targeted CAR-T cell therapy
- (2022) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials
- (2021) Philippe Rochigneux et al. Cancers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Evolving AAV-delivered therapeutics towards ultimate cures
- (2021) Xiangjun He et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma
- (2021) Jing-Jun Nie et al. JOURNAL OF CONTROLLED RELEASE
- Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
- (2021) Xiang-Yuan Luo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Poly(beta-amino ester) Nanoparticles Enable Tumor-Specific TRAIL Secretion and a Bystander Effect to Treat Liver Cancer
- (2021) Hannah J. Vaughan et al. Molecular Therapy-Oncolytics
- Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma
- (2021) Dominik Witzigmann et al. JOURNAL OF CONTROLLED RELEASE
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Concepts in Oncolytic Adenovirus Therapy
- (2021) Klaus Mantwill et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Surface tailored zein as a novel delivery system for hypericin: Application in photodynamic therapy
- (2021) Ahmed M. Abdelsalam et al. Materials Science & Engineering C-Materials for Biological Applications
- Immunotherapies for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma
- (2021) Haohao Yin et al. ACS Central Science
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease
- (2020) Marius Maximilian Woitok et al. Cell Death & Disease
- Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
- (2020) Luca Rinaldi et al. Cancers
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
- (2020) Michael S Lee et al. LANCET ONCOLOGY
- A Lactose‐Derived CRISPR/Cas9 Delivery System for Efficient Genome Editing In Vivo to Treat Orthotopic Hepatocellular Carcinoma
- (2020) Yu Qi et al. Advanced Science
- lncRNA- RP11-156p1.3, novel diagnostic and therapeutic targeting via CRISPR/Cas9 editing in hepatocellular carcinoma
- (2020) Hebatalla Said Ali et al. GENOMICS
- Systematic Characterization of the Biodistribution of the Oncolytic Virus M1
- (2020) Jing Cai et al. HUMAN GENE THERAPY
- Ginger Extract Loaded into Chitosan Nanoparticles Enhances Cytotoxicity and Reduces Cardiotoxicity of Doxorubicin in Hepatocellular Carcinoma in Mice
- (2020) Hend E. Abo Mansour et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core–Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy
- (2020) Bing-Chen Zhang et al. ACS Applied Materials & Interfaces
- Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States
- (2019) Nicole E. Rich et al. Clinical Gastroenterology and Hepatology
- Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience
- (2019) Luca Rinaldi et al. DIGESTIVE DISEASES AND SCIENCES
- CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
- (2019) Lynsey M. Whilding et al. Cancers
- Gene Therapy
- (2019) Katherine A. High et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
- (2019) M. Moehler et al. OncoImmunology
- Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
- (2019) Mark Yarchoan et al. CANCER RESEARCH
- Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
- (2019) Anroop B. Nair et al. MOLECULES
- Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma
- (2018) Kuan-Wei Huang et al. BIOMACROMOLECULES
- A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice
- (2018) Chun-Hung Liu et al. HEPATOLOGY
- An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma
- (2018) Bo Zhang et al. PLoS One
- Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies
- (2018) Shangjun Sun et al. Journal of Immunology Research
- Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
- (2018) Giulia Marelli et al. Frontiers in Immunology
- Galactosylated chitosan Triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms
- (2018) Yan-Qiong Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage
- (2018) Cheng-Chieh Fang et al. Scientific Reports
- Discovery of Bacterial Deaminases That Convert 5-Fluoroisocytosine Into 5-Fluorouracil
- (2018) Agota Aučynaitė et al. Frontiers in Microbiology
- Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
- (2018) Ian Lai et al. Journal for ImmunoTherapy of Cancer
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH)
- (2017) Jyoti Srivastava et al. HEPATOLOGY
- PTEN and TRAIL genes loaded zein nanoparticles as potential therapy for hepatocellular carcinoma
- (2017) Fathia Zaki El Sharkawi et al. JOURNAL OF DRUG TARGETING
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- Apoptin Gene Delivery by the Functionalized Polyamidoamine (PAMAM) Dendrimer Modified with Ornithine Induces Cell Death of HepG2 Cells
- (2017) Yoonhee Bae et al. Polymers
- Magnetic Cationic Amylose Nanoparticles Used to Deliver Survivin-Small Interfering RNA for Gene Therapy of Hepatocellular Carcinoma In Vitro
- (2017) Zhuo Wu et al. Nanomaterials
- Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
- (2017) Zhiwu Jiang et al. Frontiers in Immunology
- Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model
- (2017) Sibu P. Kuruvilla et al. PLoS One
- Vectorized Gene Therapy of Liver Tumors: Proof of Concept of TG4023 (MVA-FCU1) in Combination with Flucytosine
- (2016) F. Husseini et al. ANNALS OF ONCOLOGY
- Immunity, tolerance and autoimmunity in the liver: A comprehensive review
- (2016) Derek G. Doherty JOURNAL OF AUTOIMMUNITY
- Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma
- (2016) Yi-Gang Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
- (2016) Wan-Jiang Xue et al. Scientific Reports
- Image-aided Suicide Gene Therapy Utilizing Multifunctional hTERT-targeting Adenovirus for Clinical Translation in Hepatocellular Carcinoma
- (2016) Yun-Hee Kim et al. Theranostics
- Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and αVβ3 Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells
- (2016) Jiale Li et al. PLoS One
- Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC)
- (2015) Devaraja Rajasekaran et al. BIOCONJUGATE CHEMISTRY
- Talimogene Laherparepvec: First Global Approval
- (2015) Sarah L. Greig DRUGS
- Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells
- (2015) Jing Zhong et al. Hepatobiliary & Pancreatic Diseases International
- Novel hydroxybutyl chitosan nanoparticles for siRNA delivery targeting tissue factor inhibits proliferation and induces apoptosis in human vascular smooth muscle cells
- (2015) KANG WAN et al. Molecular Medicine Reports
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model
- (2015) Kui Wang et al. Small
- YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression
- (2015) Julien Fitamant et al. Cell Reports
- Superparamagnetic iron oxide nanoparticles mediated 131I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice
- (2014) Jing Chen et al. BMC CANCER
- Biological Effects of Irradiating Hepatocellular Carcinoma Cells by Internal Exposure with 125I-Labeled 5-Iodo-2′-Deoxyuridine-Chitosan Drug Loading Nanoparticles
- (2014) Chen Yang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice
- (2014) Magda Nasr et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Therapeutic efficacy of improved α-fetoprotein promoter-mediated tBid delivered by folate-PEI600-cyclodextrin nanopolymer vector in hepatocellular carcinoma
- (2014) Bao-guang Hu et al. EXPERIMENTAL CELL RESEARCH
- The First Journal on Human Gene Therapy Celebrates its 25th Anniversary
- (2014) James M. Wilson HUMAN GENE THERAPY
- Anti-Tumor Immune Response of Folate-Conjugated Chitosan Nanoparticles Containing the IP-10 Gene in Mice with Hepatocellular Carcinoma
- (2014) Chunhui Lai et al. Journal of Biomedical Nanotechnology
- Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice
- (2014) Roman L. Bogorad et al. Nature Communications
- Improving the safety of cell therapy products by suicide gene transfer
- (2014) Benjamin S. Jones et al. Frontiers in Pharmacology
- The promise of sonodynamic therapy
- (2013) Matthew Trendowski CANCER AND METASTASIS REVIEWS
- Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
- (2013) S. Kalathil et al. CANCER RESEARCH
- Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
- (2013) Shu-hao Hsu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene
- (2013) LILI QU et al. ONCOLOGY REPORTS
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma
- (2012) Y Marukawa et al. CANCER GENE THERAPY
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Live and Let Die: A New Suicide Gene Therapy Moves to the Clinic
- (2012) Richard A Morgan MOLECULAR THERAPY
- Hypoxia targeted bifunctional suicide gene expression enhances radiotherapy in vitro and in vivo
- (2012) Xiaorong Sun et al. RADIOTHERAPY AND ONCOLOGY
- Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination
- (2012) Céline Verheust et al. VACCINE
- Lipid-Based Drug Delivery Systems for Cancer Treatment
- (2011) J. L. Arias et al. CURRENT DRUG TARGETS
- Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging
- (2011) K C Sia et al. GENE THERAPY
- Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
- (2010) David Escors et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma
- (2010) B Sangro et al. CANCER GENE THERAPY
- Pegylated immuno-lipopolyplexes: A novel non-viral gene delivery system for liver cancer therapy
- (2010) Yurong Hu et al. JOURNAL OF CONTROLLED RELEASE
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea
- (2010) Luciano A. Marraffini et al. NATURE REVIEWS GENETICS
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
- (2009) Q. Gao et al. CLINICAL CANCER RESEARCH
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now